Johnson & Johnson (NYSE:JNJ) said today it launched its Cerenovus brand, which combined its Pulsar Vascular and Neuravi acquisitions and its remaining Codman Neuro neurological portfolio. Cerenovus was launched at the European Society of Minimally Invasive Neurological Therapy’s 9th annual meeting, J&J said. Johnson & Johnson said that the Cerenovus product portfolio aims to help improve stroke care, with the number […]
Neurological
Welcome to MassDevice's Neurological Hub, your resource for the latest news in the neurological device space. Stay informed about the innovations and business news shaping the neurological industry.
🧠 Narrow your focus with these categories:
Neuromodulation/Neurostimulation | Bioelectronic Medicine | Pain Management | Brain-Computer Interfaces
Here are the top neurological device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ 7 brain-computer interface companies you need to know
+ Brain breakthroughs: Aprinoia Therapeutics’ harnesses AI and strategic partnerships to propel neurodegenerative disease research
+ Natalizumab and PML: The complex dance of benefit and risk for MS
Latest Neurological News
BrainScope raises $16m for TBI assessment device
BrainScope said yesterday that it closed a $16 million funding round for the eponymous traumatic brain injury assessment device it developed. Bethesda, Md.-based BrainScope said new backer DBL Partners joined existing investors Revolution LLC, ZG Ventures, Maryland Venture Fund participated in the round, along with unnamed existing and new investors in the round. “We are delighted to […]
FDA clears Danaher’s Leica Microsystem’s FL560 cerebrovascular fluorescence microscope filter
Danaher‘s (NYSE:DHR) Leica Microsystems said yesterday it won FDA 510(k) clearance for its FL560 fluorescence microscope filter designed for visualizing cerebrovascular blood flow when used in conjunction with dye fluorescein. The filter is designed to be integrated into a M530 OH6 neurosurgical microscope to provide real-time, high-contrast visualization of cerebral anatomy in native color and […]
Acorda shares plunge -30% after FDA refuses to review NDA
Shares in Acorda Therapeutics (NSDQ:ACOR) dropped nearly -30% today after the FDA told the company that the new drug application for its inhaled Parkinson’s disease treatment is incomplete. The FDA’s refusal to file letter surprised analysts. The note from the regulatory agency had to do with the date when the manufacturing site would be ready for inspection […]
Titan wins FDA nod to study Parkinson’s implant
Titan Pharmaceuticals (NSDQ:TTNP) said today that the FDA cleared the investigational new drug application for its ropinirole implant designed to treat the symptoms of Parkinson’s disease. The Phase I/II trial, which is slated to enroll 20 patients with idiopathic Parkinson’s disease, will transition patients taking oral ropinirole to Titan’s ropinirole implant for three months of treatment, […]
Novartis launches MS study using data collected from smartphones
Novartis (NYSE:NVS) said today that it is launching a research study to better understand the daily challenges facing people with multiple sclerosis. The study is designed to collect data from physical tasks and symptoms using participants’ smartphones. The company said it hopes to find new potential ways to measure treatment effectiveness. Get the full story at […]
Battelle touts improved control with NeuroLife neural bypass system
Researchers at Battelle this week touted that the 1st user of its experimental NeuroLife system, designed to restore upper body mobility control to paralyzed patients through mental control, has shown improved control smoothness and accuracy with the system. The groups newest achievements are included in a peer-reviewed scientific paper published this week in Nature‘s Scientific […]
Alzeca Biosciences raises $11m for Alzheimer’s diagnostic imaging agent
Alzeca Biosciences said today that it raised $11 million in a Series A round to fund the development of its MRI imaging agent designed for the early diagnosis of Alzheimer’s disease and other neurodegenerative disorders. The company touts its ADx nanoparticle as the first MRI contrast agent to target amyloid – a brain protein linked to […]
Amneal Pharmaceuticals issues voluntary recall of lorazepam droppers
Amneal Pharmaceuticals said today that it is voluntarily recalling 13 lots of its oral lorazepam product due to a defect in the dosing dropper. In some cases, the dropper is printed with the dose markings in reverse order or has no dose markings at all, according to the Bridgewater, N.J.-based company. So far, no adverse events […]
MIT researchers developing device to pump drugs to the brain
Researchers at the Massachusetts Institute of Technology are developing a pump to deliver drugs directly to the brain, they even found a natural way on how to make CBD oil for special patients. Alejandro Aponte, a mechanical engineering major at the University of Puerto Rico, has spent his summer working with Michael Cima, a professor of engineering, […]
Neural Analytics launches study of transcranial doppler for evaluating mild-TBI
Neural Analytics said today it enrolled the 1st patient in a 2-year study exploring the use of its Lucid M1 transcranial doppler ultrasound system to evaluate cerebral blood flow in patients with mild traumatic brain injuries. The Lucid M1 system is a portable all-in-one ultrasound system designed for measuring and displaying cerebral blood flow velocities […]